{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-008592","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2024-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.749088+00:00","generated_at":"2026-06-04T11:38:17.419588+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Genprex raises $6.5M in registered direct offering with warrants; existing warrants amended","bullets":["Gross proceeds $6.5M; net estimated ~$5.8M after placement agent fees and expenses.","Offers 1,542,112 shares or pre-funded warrants plus 1,542,112 warrants at $4.215 per unit.","Warrants exercisable at $4.09 per share, expire 5 years from issuance.","Amends existing warrants for 194,248 shares from $44/$35.40 to $4.09 exercise price; extends expiration to 5 years from closing.","H.C. Wainwright acts as placement agent; receives 7% cash fee and 92,527 placement agent warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-008592","json":"https://secwatch.observer/filing/0001437749-24-008592.json","markdown":"https://secwatch.observer/filing/0001437749-24-008592.md","text":"https://secwatch.observer/filing/0001437749-24-008592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924008592/0001437749-24-008592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924008592/gnpx20240305_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T11:38:17.419588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c2649b47aefa25f4fd04341d49f27a1303fd305","claim":"Genprex, Inc. entered into Purchase Agreement with an institutional investor valued at approximately $5.8 million (effective 2024-03-19).","evidence_excerpt":"On March 19, 2024, Genprex, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924008592/0001437749-24-008592-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an institutional investor"},{"label":"Value","value":"approximately $5.8 million"},{"label":"Effective","value":"2024-03-19"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}